- €482.53m
- €937.53m
- €3.25bn
REG - Prosus NV Naspers Limited - Transaction in Own Shares
AnnouncementRCS - IGEA Pharma N.V. - THE LISTING OF THE NEW SHARES GRANTED
AnnouncementRCS - IGEA Pharma N.V. - IGEA EQUITY OFFER TO BLUE SKY NATURAL RESOURCES
AnnouncementRCS - IGEA Pharma N.V. - IGEA ANNOUNCES ANNUAL GENERAL MEETING RESOLUTIONS
AnnouncementRCS - IGEA Pharma N.V. - IGEA TO LAUNCH OFFER
AnnouncementRCS - IGEA Pharma N.V. - IGEA announces changes in its board
AnnouncementRCS - IGEA Pharma N.V. - IGEA disclosed its Annual Report 2020
AnnouncementRCS - IGEA Pharma N.V. - SIX approval to delay 2020 annual report
AnnouncementRCS - IGEA Pharma N.V. - IGEA: extraordinary general meeting results
AnnouncementRCS - IGEA Pharma N.V. - IGEA and its CFO end collaboration
AnnouncementRCS - IGEA Pharma N.V. - IGEA calls extraordinary general meeting
AnnouncementRCS - IGEA Pharma N.V. - IGEA announces three new board members
AnnouncementRCS - IGEA Pharma N.V. - IGEA announces changes in its board
AnnouncementRCS - IGEA Pharma N.V. - Update on business combination
AnnouncementRCS - IGEA Pharma N.V. - IGEA ensures 'Alz1' supply for the EU market
AnnouncementRCS - IGEA Pharma N.V. - IGEA announces changes in its board
AnnouncementRCS - IGEA Pharma N.V. - IGEA announces annual general meeting resolutions
AnnouncementRCS - IGEA Pharma N.V. - IGEA announces changes in its board
AnnouncementRCS - IGEA Pharma N.V. - High quality of IGEA's COVID-19 rapid test
Announcement